VentureBeat November 8, 2021
Google’s parent company Alphabet last week launched a subsidiary focused on AI-powered drug discovery called Isomorphic Labs. Helmed by Demis Hassabis, the cofounder of DeepMind, Isomorphic will use AI to identify disease treatments that have thus far eluded researchers, according to a blog post.
“Isomorphic Labs [is] a commercial venture with the mission to reimagine the entire drug discovery process from the ground up with an AI-first approach,” Hassabis wrote. “[Ultimately, we hope] to model and understand some of the fundamental mechanisms of life … There may be a common underlying structure between biology and information science — an isomorphic mapping between the two — hence the name of the company.”
The launch of Isomorphic underlines the pressure on corporate-backed...